Exvivo experiments of human ovarian cancer ascites-derived exosomes presented by dendritic cells derived from umbilical cord blood for immunotherapy treatment

Clinical Medicine: Oncology

Volumn 2, Issue , 2008, Pages 461-467

  Li, Qi Ling ^a   Bu, Ning ^b   Yu, Yue Cheng ^a   Hua, Wei ^a   Xin, Xiao Yan ^a,c  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c NONE

Author keywords

Dendritic cells; Exosome; Immunotherapy; Ovarian cancer; Umbilical cord blood

Indexed keywords

EID: 84875033566     PISSN: None     EISSN: 11779314     Source Type: Journal    
DOI: 10.4137/cmo.s776     Document Type: Article

References (22)

1. Raposo, G., Nijman, H.W., Stoorvogel, W. et al. 1996. B lymphocytes secrete antigen-presenting vesicles. J. Exp. Med., 183(3):1161-72.
2. Denzer, K., Kleijmeer, M.J., Heijnen, H.F. et al. 2000. Exosome: from internal vesicle of the multivesicular body to intercellular signaling device. J. Cell. Sci., 113 Pt(19):3365-74.
3. Thery, C., Zitvogel, L. and Amigorena, S. 2002. Exosomes: composition, biogenesis and function. Nat. Rev. Immunol., 2(8):569-79.
4. Wolfers, J., Lozier, A., Raposo, G. et al. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med., 7(3):297-303.
5. Andre, F., Schartz, N.E., Chaput, N. et al. 2002. Tumor-derived exosomes: a new source of tumor rejection antigens. Vaccine, 20(Suppl 4):A28-31.
6. Barker, J.N., Krepski, T.P., DeFor, T.E. et al. 2002. Searching for unrelated donor hematopoietic stem cells: availability and speed of umbilical cord blood versus bone marrow. Biol. Blood Marrow Transplant., 8(5):257-60.
7. Gluckman, E., Rocha, V. and Chevret, S. 2001. Results of unrelated umbilical cord blood hematopoietic stem cell transplant. Transfus. Clin. Biol., 8(3):146-54.
8. Rocha, V., Wagner, J.E. Jr., Sobocinski, K.A. et al. 2000. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell. Sources. N. Engl. J. Med., 342(25):1846-54.
9. Srivastava, P.K. 1997. Purification of heat shock protein-peptide complexes for use in vaccination against cancers and intracellular pathogens. Methods, 12(2):165-71.
10. Bard, M.P., Hegmans, J.P., Hemmes, A. et al. 2004. Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am. J. Respir. Cell. Mol. Biol., 31(1):114-21.
11. Caux, C., Vanbervliet, B., Massacrier, C. et al. 1996. CD34[[hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSFiTNF alpha. J. Exp. Med., 184(2):695-706.
12. Deshane, J., Cabrera, G., Grim, J.E. et al. 1995. Targeted eradication of ovarian cancer mediated by intracellular expression of anti-erbB-2 single-chain antibody. Gynecol. Oncol., 59(1):8-14.
13. Freedman, R.S., Tomasovic, B., Templin, S. et al. 1994. Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy. J. Immunol. Methods, 167(1-2):145-60.
14. Zitvogel, L., Regnault, A., Lozier, A. et al. 1998. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat. Med., 4(5):594-600.
15. Gansuvd, B., Hagihara, M., Higuchi, A. et al. 2003. Umbilical cord blood dendritic cells are a rich source of soluble HLA-DR: synergistic effect of exosomes and dendritic cells on autologous or allogeneic T-Cell. proliferation. Hum. Immunol., 64(4):427-39.
16. Altieri, S.L., Khan, A.N. and Tomasi, T.B. 2004. Exosomes from plasmacytoma cells as a tumor vaccine. J. Immunother., 27(4):282-8.
17. Wubbolts, R., Leckie, R.S., Veenhuizen, P.T. et al. 2003. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J. Biol. Chem., 278(13):10963-72.
18. Andre, F., Schartz, N.E., Movassagh, M. et al. 2002. Malignant effusions and immunogenic tumour-derived exosomes. Lancet, 360(9329):295-305.
19. Hegmans, J.P., Bard, M.P., Hemmes, A. et al. 2004. Proteomic analysis of exosomes secreted by human mesothelioma cells. Am. J. Pathol., 164(5):1807-15.
20. Adams, M., Navabi, H., Croston, D. et al. 2005. The rationale for combined chemo/immunotherapy using a Toll-like receptor 3 (TLR.3) agonist and tumour-derived exosomes in advanced ovarian cancer. Vaccine, 23(17-18):2374-8.
21. Taylor, D.D. and Gercel-Taylor, C. 2005. Tumour-derived exosomes and their role in cancer-associated T-cell signalling defects. Br. J. Cancer, 92(2):305-11.
22. Blanchard, N., Lankar, D., Faure, F. et al. 2002. TCR. activation of human T cells induces the production of exosomes bearing the TCR./CD3/zeta complex. J. Immunol., 168(7):3235-41.